Oncolytics Biotech Inc (ONCY): Total Liabilities
$11.38M
As of 2025-12-31
$13.84M
As of 2026-06-30
| Period ended | Total Liabilities | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $11.38M | +12.4% | 2026-03-30, Balance as of period end |
| 2024-12-31 | $10.12M | n/a | 2026-03-30, Balance as of period end |
Total Liabilities at similar companies
| Company | Year ended | Total Liabilities | Change YoY |
|---|---|---|---|
| Oncolytics Biotech Inc (ONCY) | 2025-12-31 | $11.38M | +12.4% |
| Rocket One Inc. (RKTO) | 2025-12-31 | $1.45M | +74.2% |
| Silo Pharma, Inc. (SILO) | 2025-12-31 | $1.30M | -45.3% |
| Acurx Pharmaceuticals, Inc. (ACXP) | 2025-12-31 | $2.42M | -25.3% |
| Ensysce Biosciences, Inc. (ENSC) | 2025-12-31 | $4.57M | +106.0% |
| Processa Pharmaceuticals, Inc. (PCSA) | 2025-12-31 | $2.24M | +45.9% |
| Telomir Pharmaceuticals, Inc. (TELO) | 2025-12-31 | $1.43M | +109.7% |
| Dermata Therapeutics, Inc. (DRMA) | 2025-12-31 | $1.64M | -16.8% |
| Matinas BioPharma Holdings, Inc. (MTNB) | 2025-12-31 | $2.38M | -52.9% |
Compare ONCY, RKTO, SILO, ACXP side by side · Screen every company in Pharmaceutical Preparations ↗